Meanwhile, prostate tumors tend to evade antitumor immune cells through the secretion of immunosuppressive factors such as interleukin 1 beta (IL-1β), IL-10, and TGF-β in the TME and thereby induce the differentiation of myeloid cells into myeloid-derived suppressor cells (MDSCs). This evidence concerns the gene IL1B and prostate neoplasm.